EcoDrugPlus

Kallikrein B1

Ensembl ID : ENSCDRG00005011771
Gene Symbol: KLKB1
1 Cross references
209 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSCDRG00005007359
Gene Symbol: KEAP1
3 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSCDRG00005002066
Gene Symbol: KDR
1 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCDRG00005015805
Gene Symbol: KIF11
3 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSCDRG00005019986
Gene Symbol: KIF5B
1 Cross references
288 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCDRG00005019737
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor 2

Ensembl ID : ENSCDRG00005006450
Gene Symbol: LTB4R2
1 Cross references
238 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCDRG00005014888
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSCDRG00005016177
Gene Symbol: LOXL2
1 Cross references
288 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSCDRG00005022001
Gene Symbol: MIF
1 Cross references
220 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSCDRG00005006950
Gene Symbol: MST1R
3 Cross references
268 Possible Orthologues:

Maltase-Glucoamylase

Ensembl ID : ENSCDRG00005005484
Gene Symbol: MGAM
3 Cross references
312 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).